Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Jun 18, 2010


Predictive Biosciences announced this week that Jay Moorin has joined its board of directors.

Moorin is a founding partner at ProQuest Investments, which led a recent Series C funding round through which Predictive raised $25 million (see related story, this issue).

Prior to founding ProQuest, Moorin was CEO of Magainin Pharmaceuticals (now Genaera), and prior to that he was managing director of healthcare banking at Bear Stearns.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.